Assyro AI

FDA PDUFA dates in December 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in December 2026, sourced from FDA primary records.

Tracking 6 published FDA PDUFA decisions, including 4 NDAs and 2 BLAs.

FDA PDUFA dates in December 2026: 6 published FDA PDUFA target action dates.
SponsorProductTypeApplicationPDUFA dateStatus
Exelixiszanzalintinib + atezolizumabNDAPENDING-provisional|exelixis|zanzalintinibatezolizumab|pupcoming
Vanda and AnaptysBioimsidolimabBLAPENDING-provisional|vandaandanaptysbio|imsidolimab|generupcoming
Rochegiredestrant + everolimusNDAPENDING-provisional|roche|giredestranteverolimus|advanceupcoming
Mineralys TherapeuticslorundrostatNDAPENDING-provisional|mineralystherapeutics|lorundrostat|hupcoming
Arcellx and Gileadanitocabtagene autoleucelBLAPENDING-provisional|arcellxandgilead|anitocabtageneautolupcoming
Cogent BiosciencesbezuclastinibNDAPENDING-provisional|cogentbiosciences|bezuclastinib|nonaupcoming

Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

December 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track December 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.